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Summary
Morphogenesis, the development of shape or form in cells or
organisms, is a fundamental but poorly understood process
throughout biology. In the bacterial domain, cells have a
wide range of characteristic shapes, including rods, cocci,
and spirals. The cell wall, composed of a simple meshwork
of long glycan strands crosslinked by short peptides (pepti-
doglycan, PG) and anionic cell wall polymers such as wall
teichoic acids (WTAs), is the major determinant of cell
shape. It has long been debated whether the formation of
new wall material or the transmission of shape from parent
to daughter cells requires existing wall material as a tem-
plate [1–3]. However, rigorous testing of this hypothesis
has been problematical because the cell wall is normally
an essential structure. L-forms are wall-deficient variants
of common bacteria that have been classically identified as
antibiotic-resistant variants in association with a wide range
of infectious diseases [4–6]. We recently determined the
genetic basis for the L-form transition in the rod-shaped bac-
terium Bacillus subtilis and thus how to generate L-forms
reliably and reproducibly [7, 8]. Using the new L-form sys-
tem, we show here that we can delete essential genes for
cell wall synthesis and propagate cells in the long-term
absence of a cell wall template molecule. Following genetic
restoration of cell wall synthesis, we show that the ability
to generate a classical rod-shaped cell is restored, conclu-
sively rejecting template-directed models, at least for the
establishment of cell shape in B. subtilis.Results and Discussion
It is well known that treatment of bacterial cells with cell wall-
active antibiotics or enzymes such as lysozymes converts
them to cell wall-deficient protoplasts, which can be main-
tained in an osmoprotective medium (though with little net
growth [8]). Such protoplasts can then be regenerated to pro-
duce viable, walled cells with normal morphology [2], albeit at
low efficiency (reviewed by Hopwood [9]). In these experi-
ments, it is difficult to exclude the presence of residual cell
wall template fragments because synthesis and assembly of
the wall can continue via newly synthesized precursors or cat-
alytic enzymes (Figure 1A) [10–13]. However, bacterial variants
called L-forms [5] are capable of prolonged growth in the
absence of cell wall synthesis and thus might be suited to a
definitive test of the need for a cell wall template. Because
they are largely or completely lacking in cell wall, the basic
shape of L-forms is spherical, but they are highly malleable*Correspondence: y.kawai@ncl.ac.uk (Y.K.), jeff.errington@ncl.ac.uk (J.E.)
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creativecommons.org/licenses/by/3.0/).and take on an array of irregular shapes influenced by the
surrounding milieu. L-forms have often been classified as
‘‘stable,’’ in which case the cells can be propagated in the
L-form state indefinitely, or as ‘‘unstable’’ for strains capable
of reverting to the normal walled state. In principle, the
existence of unstable L-forms suggests that a defined cell
shape can be generated de novo. However, recent work on
Escherichia coli L-forms suggests that unstable L-forms retain
the requirement for at least a low level of cell wall synthesis,
because genes essential for cell wall synthesis or assembly
remain essential in the unstable L-forms [14, 15].
We have been developingmethods for generating L-forms of
the Gram-positive model bacterium Bacillus subtilis [7, 8, 16].
We found that at least two mutations are normally required for
L-form growth. One mutation (e.g., ispA) has a poorly defined
role in maintaining cell integrity and is probably of little
direct functional significance. The key mutations enabling
proliferation in the L-form state appear to work simply by
increasing the rate of membrane synthesis. L-forms proliferate
by a strange mechanism of membrane blebbing, or tubulation
and fission [7]; it seems that excessmembrane synthesis is suf-
ficient to drive this mode of cell division [8]. Genetic screens re-
vealed two classes of mutation that can generate the excess
membraneeffect.Oneclass (i.e., overexpressionof thegeneen-
coding the catalytic subunit of acetyl-coenzyme A-carboxylase
[AccDA] [8]) leads directly to upregulation of the fatty acid syn-
thetic pathway and hence to increased membrane synthesis.
The other class, inhibition of cell wall precursor synthesis (e.g.,
by repression of the murE operon [7]), works indirectly by an
as yet uncharacterized mechanism. Nevertheless, the fact that
repression of peptidoglycan (PG) precursor synthesis can pro-
mote the L-form transition provides a means, in principle, of
testing whether continued PG synthesis is needed to maintain
the ability to regenerate a rod-shaped walled cell (Figure 1B).
In our previouswork,we identifiedan18kbpdeletion that en-
ables stable proliferation of L-forms [8]. This deletion removed
themurC gene, which encodes an essential enzyme in the PG
precursor pathway, together with 17 other coding regions of
mainly unknown function. (We assume that one or more of
the other genes deleted confer a stabilizing effect similar to
that of the ispA mutation mentioned above, although we have
not yet fully characterized the effect.) We reconstructed the
18 kbp deletion by replacement with a tetracycline resistance
gene (D18::tet) (Figure 1C) and showed that the resultant strain
had the expected phenotype [8]. The D18::tet mutation was
introduced into wild-type cells by a standard B. subtilis trans-
formation method (see Experimental Procedures). Transform-
ants were selected on our standard L-form plates (nutrient
agar [NA]/magnesium-sucrose-maleic acid [MSM]) containing
tetracycline. The plates contain an osmoprotectant (sucrose)
and an inhibitor of cell division (benzamide [17]) that inhibits
the growth of walled cells, but not of L-forms. After w3–
4 days at 30C, small tetracycline- and benzamide-resistant
colonies were visible (Figure 2A; the three large colonies
marked by arrows contained rod-shaped walled cells and
were presumably spontaneous tetracycline-resistant mutants
or some kind of merodiploid recombinants). Phase-contrast
microscopy of the small colonies revealed only L-form cells
(Figure 2B). We confirmed the presence of the D18::tet
Figure 2. Inhibition of PG Precursor Synthesis by Deleting murC
(A) Transformation of wild-typewalled cells to L-forms by introduction of the
D18::tet mutation, which completely deletes the murC gene as well as 17
other genes. Colonies of D18::tet L-forms were selected on transformation
plates (NA/MSM) containing tetracycline and benzamide. The plate was
incubated for 4 days at 30C after transformation. An enlarged image of
the typical colonies (dashed square) is shown to the right. Arrows point to
large dense colonies that were of spurious origin and contained walled
rod-shaped cells.
(B) Phase-contrast micrograph of D18::tet L-forms from a colony on the
transformation plate shown in (A). Scale bar represents 5 mm.
(C) Growth of wild-type protoplasts (WT, blue) and D18::tet L-forms
(D18::tet, red) in L-form-supporting medium (NB/MSM) with benzamide.
Cells were incubated at 30C.
(D) Induction of cell wall regeneration from L-forms of strain RM84 [8]
(accDA* ispA*) or D18::tet. Proliferating L-form cultures (OD600 = w0.2–
0.3) in L-form medium (NB/MSM) with penicillin G (PenG) and benzamide
were spotted onto L-form plates (NA/MSM) without PenG and benzamide.
The plates were incubated for 3 days at 30C.
(E) Phase-contrast micrograph of proliferating L-forms of strain RM84
(accDA* ispA*) in L-formmedium (NB/MSM)with penicillin G and benzamide
(left), and after induction of cell wall regeneration by cultivating L-forms (left)
on L-form plates (NA/MSM) in the absence of PenG and benzamide (right).
Phase-contrast micrograph of rod-shaped cells was taken from a colony
shown in (D) (accDA* ispA*). Scale bar represents 5 mm.
(F) Phase-contrast micrograph of proliferating L-forms of D18::tet in L-form
medium with penicillin G and benzamide (left) or from the L-form regenera-
tion plate (no penicillin G or benzamide) shown in (D) (D18::tet) (right). Scale
bar represents 5 mm.
Figure 1. Schematic View of Peptidoglycan Synthesis and the Models for
Cell Morphogenesis
(A) The peptidoglycan (PG) cell wall is built from long glycan strands
composed of N-acetylmuramic acid (MurNAc) and N-acetylglucosamine
(GlcNAc) crosslinked by peptide cross-bridges [10, 11]. The precursor for
PG is initially synthesized in the cytoplasm by the action of MurAA, MurB,
MurC, MurD, MurE, and MurF enzymes. MurNAc-pentapeptide is coupled
to a membrane carrier, undecaprenyl pyrophosphate, by MraY, and GlcNAc
is added by MurG to form lipid II, which is then transferred to the outside of
the cytoplasmic membrane. Newly synthesized PG is incorporated into the
existing PG meshwork by a combination of transglycosylation and trans-
peptidation reactions catalyzed by penicillin-binding proteins. Wall teichoic
acids (WTAs) are abundant PG-linked glycopolymers present inmost Gram-
positive organisms and are essential for maintaining rod shape in B. subtilis
[12]. WTA synthesis begins at the cytoplasmic side of membrane with the
coupling of GlcNAc to the same lipid carrier, undecaprenyl pyrophospate,
as is used for PG precursors. WTA polymer synthesis requires the action
of series of enzymes (TagA, TagB, TagD, TagE, and TgaF) in the cytosol.
The polymer is exported and coupled to the PG by the action of the TagTUV
enzymes [13].
(B) Models for bacterial cell morphogenesis. It has not been clear whether
the formation of new wall material and the transmission of rod shape
from parent to daughter cells require existing wall material as a template
(see text).
(C) Schematic representation of the chromosomal region deleted in D18::tet
L-forms [8].
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864mutation and deletion of the murC gene by PCR (see below).
Consistent with our previous work [8], the newly selected
L-forms were able to grow in liquid L-form medium (nutrient
broth [NB]/MSM) in contrast to wild-type protoplasts not
bearing the D18::tet mutation (Figure 2C). Certain types of L-
forms are known to be able to regenerate cell wall and shape
in the absence of selection pressure such as b-lactam antibi-
otics [5]. Proliferating L-forms induced by AccDA overproduc-
tion (accDA* ispA*), and thus with an intact PG synthetic
pathway, were indeed able to revert to the walled state, when
spotted onto L-form plates without penicillin G. The left-hand
spot in Figure 2D shows the emergence of dense colonies,
which contained classical rod-shaped walled cells (Figure 2E,
right panel). However, complete deletion ofmurC, e.g., by the
D18::tet mutation, irreversibly blocks the PG precursor syn-
thetic pathway and thus prevents regeneration of the cell wall
(Figures 2D, right-hand spot with no dense growth, and 2F).
Having established a stable L-form strain incapable of cell
wall synthesis, we wished to test whether the resumption ofPG precursor synthesis would enable the regeneration of a
PG cell wall and the restoration of rod-shaped cells. We
attempted to introduce an isopropyl b-D-thiogalactoside
(IPTG)-inducible ectopic copy of murC on a plasmid (pLOSS-
Pspac-murC lacZ erm
R [8]) into the D18::tet L-form strain by
modifying an established polyethylene glycol (PEG)-mediated
protoplast transformation method [18] (see details in Experi-
mental Procedures). Transformantswere selectedonNA/MSM
Figure 3. Cell Wall and Cell Shape Regeneration by the Restoration of PG
Precursor Synthesis
(A) Restoration of the cell wall and cell shape in D18::tet L-forms by reintro-
duction of themurC gene on aplasmid (pLOSS-Pspac-murC erm
R lacZ) using
a PEG-dependent L-form transformation method (see text). Transformants
were selected on an NA/MSM plate containing erythromycin and 2 mM
IPTG. The plate was incubated for 3 days at 30C after transformation. An
enlarged image of the typical colonies (dashed square) is shown to the right.
(B) Phase-contrast micrograph of cells from a typical colony on the transfor-
mation plate in (A). Scale bar represents 5 mm.
(C) A transformant from the plate shown in (A) (D18::tet + pLOSS-murC) and
a wild-type control strain were streaked on NA plates containing X-gal with
or without IPTG.
(D) PCR analysis for integration or removal of the D18::tetmutation and the
murC gene in various strains: wild-type (lane 1), RM121(lane 2), D18::tet
L-forms (lane 3), and D18::tet + pLOSS-Pspac-murC (lane 4). RM121
(D18::tet + pLOSS-Pspac-murC) was constructed in previous work [8] and
was used as a control.
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the murC gene on the plasmid, Pspac-murC) at 30
C. After
w3–4 days, several erythromycin-resistant colonies appeared
(Figure 3A). No colonies were seen on selective plates in con-
trols lacking recipient L-forms, donor plasmid, or PEG treat-
ment for transformation (data not shown). Phase-contrast
microscopy revealed that these colonies were formed by
walled cells with typicalB. subtilis rod-shapemorphology (Fig-
ure 3B). The colony-purified strain was able to grow on NA
plates (without osmoprotectants) in the presence of IPTG,
giving colonies that were blue in the presence of 5-bromo-4-
chloro-3-indolyl-b-D-galactopyranoside (X-gal) due to expres-
sion of lacZ (b-galactosidase) from the pLOSS plasmid [19]
(Figure 3C). We also confirmed the reintroduction of themurC
gene intoD18::tet L-formsbyPCR (Figure 3D, lane 4). These re-
sults demonstrated that cells that have been propagated for a
long period of time (at least 3 months; the proliferating L-form
culture was maintained by diluting into fresh medium once
per week) in a state in which they are unable to synthesize PG
through loss of a key enzyme, are nevertheless able to regen-
erate a normal cellmorphology on restoration ofwall synthesis.
To rule out the possibility of even a small amount of cell wall
synthesis, we decided to build a host strain with an additional
deletion in the uppS gene. The UppS product is a normally
essential protein required for synthesis of undecaprenyl pyro-
phosphate (bactoprenol). Bactoprenol is an isoprenoid lipid
carrier used for synthesis and export of precursors for bothPG andwall teichoic acids (WTAs) (Figure 1A). We constructed
a uppS deletion mutant in the presence of an IPTG-inducible
copy of uppS carried on an unstable pLOSS plasmid (strain
YK1888,DuppS::kan pLOSS-Pspac-uppS). Growth of this strain
was dependent on IPTG (Figure 4Aii), confirming that uppS is
indeed essential for cell viability in normal walled cells. How-
ever, the growth defect was not fully restored in the presence
of IPTG (Figure 4A, i and ii). We realized that uppS lies immedi-
ately upstream of cdsA, which is essential for membrane
phospholipid synthesis. To avoid the polar effect on the cdsA
expression, a xylose-inducible promoter (Pxyl) was inserted in
front of the cdsA gene to give strain YK1889 (DuppS::kan Pxyl-
cdsA pLOSS-Pspac-uppS). The growth of YK1889 was similar
to that of thewild-type in thepresenceof both IPTGandxylose,
but no growthwas seen in the absence of either IPTGor xylose,
as expected (Figure 4Aiii). The D18::tet mutation was intro-
duced into this strain (YK1889) to convert to the cells to
L-forms; transformants were selected on NA/MSM L-form
plates containing tetracycline, benzamide, and xylose. After
w4–5 days, several tetracycline- and benzamide-resistant col-
onies appeared. Phase-contrast microscopy of the colonies
revealed L-form cells (Figure 4Di), and we confirmed the pres-
ence of the D18::tet mutation, together with deletion of the
murC and uppS genes by PCR (Figure 4E, lanes 2), showing
that the strain had lost the uppS expression plasmid and there-
fore that L-formsdonot requireUppSprotein.When this L-form
strain was transformed with the pLOSS-Pspac-murC plasmid,
as described above,with selection onNA/MSMplates contain-
ing erythromycin, xylose, and IPTG, no colonies were seen on
the selective plates (Figure 4B, left), consistent with expecta-
tion that the bactoprenol generated by uppS is necessary for
the resumption of cell wall synthesis. In contrast, when a deriv-
ative plasmid carrying both themurC and uppS genes (pLOSS
murC+ uppS+) was introduced into the L-form strain, several
colonies appeared (Figure 4B, right). These colonies contained
many walled cells with typical rod-shape morphology (Fig-
ure 4Dii). The colony-purified strain was able to grow with
normal rod shape on NA plates (without osmoprotectants) in
the presence of IPTG (and xylose, for the expression of cdsA)
(Figures 4C, left, and 4Diii). PCR confirmed the reintroduction
of the murC and uppS genes into D18::tet DuppS::kan Pxyl-
cdsA L-forms (Figure 4E, lanes 3).
In this report, we created a cell line in which PG synthesis is
blocked by deletion of an essential gene,murC, in the PG wall
synthetic pathway.Wewent on to generate an additional block
in assembly of the precursors to both PG and WTAs, by delet-
ing the uppS gene required for synthesis of the common lipid
carrier bactoprenol. Although we cannot exclude the possi-
bility that B. subtilis possesses a series of enzymes that can
support wall polymer synthesis by an as yet undefined mech-
anism, it seems highly likely that the double blockade we
generated would have abolished all significant wall synthesis.
We then developed a transformation method for L-forms and
returned the murC and uppS genes, enabling the resumption
of cell wall synthesis. Ultimately, we showed that de novo
PG synthesis is sufficient to regenerate the cell wall and
restore a rod-shape morphology in B. subtilis in the absence
of an existing cell wall template, conclusively excluding the
need for a cell wall template in establishment of the rod shape
of B. subtilis. What then are the mechanisms responsible for
establishment and maintenance of cell shape? Several lines
of evidence suggest that the actin-like MreB proteins play a
central role in shape determination [10, 20–22]. Although mo-
lecular details of the function of these proteins remain elusive,
Figure 4. Regeneration of Rod-Shape
Morphology by De Novo PG Synthesis in the
Absence of an Existing Cell Wall Template
(A) Effect of repression of uppS and cdsA on
growth in the walled state. The following strains
were cultured on NA plates with 1% xylose and
1 mM IPTG (left), 1 mM IPTG (middle), or without
(right) at 30C: wild-type (strain 168, i), DuppS::
kan pLOSS-Pspac-uppS (YK1888, ii), and DuppS::
kan Pxyl-cdsA pLOSS-Pspac-uppS (YK1889, iii).
(B) Regeneration of the cell wall in D18::tet
DuppS::kan Pxyl-cdsA L-forms by reintroduction
of the murC gene (pLOSS-Pspac-murC erm
R
lacZ, left) or murC and uppS genes (pLOSS-
Pspac-murC PuppS-uppS erm
R lacZ, right) using a
PEG-dependent L-form transformation method
(see text). Transformants were selected on an
NA/MSM plate containing erythromycin, 1%
xylose, and 2 mM IPTG. Plates were incubated
forw5–6 days at 30C after transformation.
(C) One of the transformants shown in (B) (right,
D18::tet DuppS::kan Pxyl-cdsA + pLOSS-Pspac-
murC PuppS-uppS erm
R lacZ) was streaked on
NA plates containing 1% xylose with (left) or
without (right) 2 mM IPTG.
(D) Phase-contrast micrograph of D18::tet
DuppS::kan Pxyl-cdsA L-forms on NA/MSM con-
taining 1% xylose (i) and of cells (D18::tet
DuppS::kan Pxyl-cdsA + pLOSS-Pspac-murC
PuppS-uppS erm
R lacZ) from a typical colony on
the transformation plate (NA/MSM with 1%
xylose and 2 mM IPTG) as shown in (B) (ii) or on
NA plate containing xylose and IPTG as shown
at left in (C) (iii). Scale bar represents 5 mm.
(E) PCR analysis for integration or removal of the
D18::tet mutation, the murC gene, and the uppS
gene in various strains: YK1889 (DuppS::kan
Pxyl-cdsA pLOSS-Pspac-uppS, lanes 1), YK1913
(D18::tet DuppS::kan Pxyl-cdsA, lanes 2), and
YK1925 (D18::tet DuppS::kan Pxyl-cdsA +
pLOSS-Pspac-murC PuppS-uppS erm
R lacZ, lanes
3). The ftsZ gene was also checked as a control.
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wall polymers during growth of the lateral wall is strong. More-
over, their ability to form extended linear filaments provides a
means, at least in principle, of exerting long-range interactions
on the cell wall synthetic machinery, leading to the control of
gross cell geometry. It will be interesting to investigate the pro-
cess whereby cell shape is reestablished, although the low fre-
quency of this event precludes detailed analysis at present.
Nevertheless, extension of the methods that we have devel-
oped for studying de novo cell wall synthesis promises to pro-
vide a powerful new means of studying the establishment of
bacterial cell morphology.
Experimental Procedures
Bacterial Strains, Plasmids, Primers, and Growth Conditions
The bacterial strains, plasmid constructs, and primers for PCR analysis in
this study are shown in Tables S1 and S2 available online. DNA manipula-
tions were carried out using standard methods. Protoplasts were prepared
as described previously [8]. Normal B. subtilis cells were grown on NA
(Oxoid) and in Luria-Bertani broth. B. subtilis L-forms and protoplasts
were grown in osmoprotective medium composed of 23 MSM (pH 7)
(40 mM MgCl2, 1 M sucrose, and 40 mM maleic acid) mixed 1:1 with 23
NB (Oxoid) or 23 NA. Details of supplements, antibiotics, and microscopic
imaging used for this study can be found in the Supplemental Information.
Selection of D18::tet L-Forms
For selection of the D18::tet L-forms, we transformed chromosomal DNA of
the strain RM121 (D18::tet pLOSS-Pspac-murC lacZ erm
R [8]) into wild-typeB. subtilis using standard methods [23]. Transformants were selected on
L-form plates (NA/MSM) containing 30 mg/ml tetracycline and 1 mg/ml
benzamide.
Transformation Method for L-Forms
L-form transformation was carried out by modifying a PEG-dependent pro-
toplast transformation method [18]. Proliferating L-form cultures (D18::tet)
were diluted at 1023 into fresh NB/MSM medium (10 ml) and incubated at
30C until OD600 = w0.2 (2 days). The culture was centrifuged at
8,000 rpm for 10 min, and the L-forms were resuspended in 300 ml of NB/
MSM medium and then mixed with 2 mg of murC expression plasmid. For
L-form transformation, 150 ml of the L-form and plasmid mixture was trans-
ferred into 450 ml of MSM containing 40% PEG6000 (Sigma-Aldrich) and
gently mixed. After 2 min, 1 ml of NB/MSM was added and mixed, and the
cells were then centrifuged at 8,000 rpm for 10 min. The cell pellet was re-
suspended in 300 ml of NB/MSM and incubated for 120 min at 30C. Finally,
a 150 ml sample of the cell suspension was plated on NA/MSM plates
containing erythromycin and IPTG. The plates were incubated at 30C.
Supplemental Information
Supplemental Information includes two tables and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.cub.2014.02.053.
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